Clonally expanded IgG, but not IgA, antibody-secreting cells preferentially target influenza nucleoprotein following homologous and heterologous infections
The Journal of Immunology · 2025
DOI: 10.1093/jimmun/vkaf144 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, 2025. Verfasst von Andreas Agrafiotis und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland. Hauptthemen laut MEDLINE: Immunoglobulin A, Immunoglobulin G, Influenza, Human, Antibody-Producing Cells. Die Arbeit nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: SNSF Ambizione Grant, SNSF Ambizione, ETH Career Seed.
Abstract (Originalsprache)
Infection with influenza virus remains a significant global health concern due to its ability to acquire mutations at key antigenic sites to escape antibody recognition. While germinal center (GC) and memory B cells have been well studied following influenza infection, the clonal dynamics of antibody secreting cells (ASCs), particularly those within the bone marrow (BM) niche that are responsible for serum immune protection, remain poorly understood. Here, we combine single-cell RNA (scRNA) and B cell receptor (BCR) sequencing to characterize individual ASCs following various Influenza exposure histories. We find that BM repertories are populated by highly expanded and class-switched ASCs following Influenza infection with similar transcriptional and repertoire characteristics regardless of homologous or heterologous infection histories. By combining single-cell analysis with monoclonal antibody expression and characterization, we find that a large proportion of the expanded IgG-, but not IgA-, ASC repertoire demonstrates specificity to influenza nucleoprotein (NP). Together, our data reveal the complex relationship between BM ASC repertoires, mucosal humoral immune responses, and BCR antigen specificity during influenza infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.
- Institute of Microbiology, ETH Zurich, Zurich, Switzerland.
- Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland.
- Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands.
- Center for Human Immunology, University of Zurich, Zurich, Switzerland.
- Botnar Institute of Immune Engineering, Basel, Switzerland.
ORCID-Profile: Andreas Agrafiotis, Sai T Reddy, Alexander Yermanos
Förderung
- SNSF Ambizione Grant
- SNSF Ambizione
- ETH Career Seed
- SNSF
Zitieren
APA
Agrafiotis, A., Kuhn, R., Panetti, C., Venerito, M., Phandee, H., Stalder, L., Shlesinger, D., Martinolli, V., Hong, K. L., van Ginneken, D., Genovese, A., Joller, N., Oxenius, A., Reddy, S. T., & Yermanos, A. (2025). Clonally expanded IgG, but not IgA, antibody-secreting cells preferentially target influenza nucleoprotein following homologous and heterologous infections. The Journal of Immunology. https://doi.org/10.1093/jimmun/vkaf144
Vancouver
Agrafiotis A, Kuhn R, Panetti C, Venerito M, Phandee H, Stalder L, et al. Clonally expanded IgG, but not IgA, antibody-secreting cells preferentially target influenza nucleoprotein following homologous and heterologous infections. The Journal of Immunology. 2025. doi:10.1093/jimmun/vkaf144
BibTeX
@article{Agrafiotis2025,
author = {Agrafiotis, Andreas and Kuhn, Raphael and Panetti, Camilla and Venerito, Marco and Phandee, Hathaichanok and Stalder, Lucas and Shlesinger, Danielle and Martinolli, Vittoria and Hong, Kai-Lin and van Ginneken, Daphne and Genovese, Alessandro and Joller, Nicole and Oxenius, Annette and Reddy, Sai T and Yermanos, Alexander},
title = {Clonally expanded IgG, but not IgA, antibody-secreting cells preferentially target influenza nucleoprotein following homologous and heterologous infections},
journal = {The Journal of Immunology},
year = {2025},
doi = {10.1093/jimmun/vkaf144}
}
EUVIMED